Literature DB >> 32805272

Validation of Dried Tube Sample Format Quality Controls for the Monitoring of Viral Load and Blood Screening Assays.

Wayne Dimech1, Giuseppe Vincini2, Kylie Davies2, Marina Karakaltsas2, Natasha Dubois van Cauwalaert3, Emilande Guichet3, Marco Koppelman4, Liza Cabuang2.   

Abstract

HIV viral load (VL) and donor screening assays experience variation and require quaity assurance (QA). NRL sought to confirm a dried tube sample format (HIVDTS) sample type for use in quality control (QC) programs for HIV molecular testing. 50 μL of HIV supernatant at 1 × 105 copies per millilitre (copies/mL)) was dried for 48 hours at room temperature. Post-production and shipped integrity studies were undertaken. Dried HIVDTS was reconstituted in PBS buffer and tested in HIV VL (six participants) or blood screening assays (four participants). Results were entered into NRL's QC monitoring software (EDCNet™) for analysis. The mean of 224 VL results when HIVDTS QCs were tested in Biocentric HIV GENERIC Charge Virale assay was 4.54 log10 copies/mL, with the percentage coefficient of variation (CV%) ranging from 1.75 to 13.20%. The mean Ct value for HIVDTS QCs tested on Roche Cobas MPX assay results was 28.71 (range 28.33 to 29.14), with CV% ranging from 1.56 to 3.98%. The study confirms HIVDTS QCs can effectively monitor the performance of HIV molecular testing and offers a cheaper alternative to commercial QC samples that require cold-chain shipping on dry ice and UN3373 conditions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dried tube samples; HIV viral load; donor screening; quality control

Mesh:

Year:  2020        PMID: 32805272     DOI: 10.1016/j.jviromet.2020.113957

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

Review 1.  A decentralised point-of-care testing model to address inequities in the COVID-19 response.

Authors:  Belinda Hengel; Louise Causer; Susan Matthews; Kirsty Smith; Kelly Andrewartha; Steven Badman; Brooke Spaeth; Annie Tangey; Phillip Cunningham; Emily Phillips; James Ward; Caroline Watts; Jonathan King; Tanya Applegate; Mark Shephard; Rebecca Guy
Journal:  Lancet Infect Dis       Date:  2020-12-23       Impact factor: 25.071

2.  Implementation of Novel Quality Assurance Program for Hepatitis C Viral Load Point of Care Testing.

Authors:  Wayne Dimech; Liza Cabuang; Kylie Davies; Giuseppe Vincini
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.